These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 489521)

  • 21. The relationship between insight and symptoms in schizophrenia.
    Sevy S; Nathanson K; Visweswaraiah H; Amador X
    Compr Psychiatry; 2004; 45(1):16-9. PubMed ID: 14671732
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Adherence to neuroleptic treatment of schizophrenic patients].
    Blondiaux I; Alagille M; Ginestet D
    Encephale; 1988; 14(6):431-8. PubMed ID: 2906607
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between attitude toward medication and neurocognitive function in schizophrenia.
    Kim SW; Shin IS; Kim JM; Yang SJ; Shin HY; Yoon JS
    Clin Neuropharmacol; 2006; 29(4):197-205. PubMed ID: 16855421
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Subjective illness theory and antipsychotic medication compliance by patients with schizophrenia.
    Holzinger A; Loffler W; Muller P; Priebe S; Angermeyer MC
    J Nerv Ment Dis; 2002 Sep; 190(9):597-603. PubMed ID: 12357093
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medication adherence failure in schizophrenia: a forensic review of rates, reasons, treatments, and prospects.
    Young JL; Spitz RT; Hillbrand M; Daneri G
    J Am Acad Psychiatry Law; 1999; 27(3):426-44. PubMed ID: 10509942
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Schizophrenia: attitudes of patients and professional carers towards the illness and antipsychotic medication.
    Rettenbacher MA; Burns T; Kemmler G; Fleischhacker WW
    Pharmacopsychiatry; 2004 May; 37(3):103-9. PubMed ID: 15138893
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is "clinical" insight the same as "cognitive" insight in schizophrenia?
    Donohoe G; Hayden J; McGlade N; O'Gráda C; Burke T; Barry S; Behan C; Dinan TG; O'Callaghan E; Gill M; Corvin AP
    J Int Neuropsychol Soc; 2009 May; 15(3):471-5. PubMed ID: 19402933
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Schizophrenia and addiction: An evaluation of the self-medication hypothesis].
    Potvin S; Stip E; Roy JY
    Encephale; 2003; 29(3 Pt 1):193-203. PubMed ID: 12876543
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An RCT of adherence therapy for people with schizophrenia in Chiang Mai, Thailand.
    Maneesakorn S; Robson D; Gournay K; Gray R
    J Clin Nurs; 2007 Jul; 16(7):1302-12. PubMed ID: 17584349
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adherence behaviour with psychotropic medication is a form of self-medication.
    Mitchell AJ
    Med Hypotheses; 2007; 68(1):12-21. PubMed ID: 16996228
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Facilitating compliance with antipsychotic medication.
    Marder SR
    J Clin Psychiatry; 1998; 59 Suppl 3():21-5. PubMed ID: 9541334
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Partial compliance with antipsychotic medication is common in patients with schizophrenia.
    Rummel-Kluge C; Schuster T; Peters S; Kissling W
    Aust N Z J Psychiatry; 2008 May; 42(5):382-8. PubMed ID: 18473256
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Insight into illness and compliance in schizophrenic disorders].
    Zsolt JL; György B
    Psychiatr Hung; 2006; 21(6):413-21. PubMed ID: 17438658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of medication adherence in patients with schizophrenia: the Achilles heel of adherence research.
    Kikkert MJ; Barbui C; Koeter MW; David AS; Leese M; Tansella M; Gieler A; Puschner B; Schene AH
    J Nerv Ment Dis; 2008 Apr; 196(4):274-81. PubMed ID: 18414121
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Compliance in the treatment of schizophrenia--project ADHES (the renewed results)].
    Chadzyńska M; Meder J; Tyszkowska M
    Psychiatr Pol; 2008; 42(4):561-70. PubMed ID: 19189600
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Medication-related attitudes of chronic schizophrenic patients. A follow-up study after psycho-educational intervention].
    Hornung WP; Schonauer K; Feldmann R; Mönking HS
    Psychiatr Prax; 1998 Jan; 25(1):25-8. PubMed ID: 9530765
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment adherence in schizophrenia. A comparison between patient's, relative's and psychiatrist's opinions].
    Giner J; Cañas F; Olivares JM; Rodriguez A; Burón JA; Rodríguez-Morales A; Roca M
    Actas Esp Psiquiatr; 2006; 34(6):386-92. PubMed ID: 17117335
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and neuropsychological correlates of insight in schizophrenia and bipolar I disorder: does diagnosis matter?
    Varga M; Magnusson A; Flekkøy K; David AS; Opjordsmoen S
    Compr Psychiatry; 2007; 48(6):583-91. PubMed ID: 17954145
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Schizophrenia with obsessive-compulsive disorder and obsessive-compulsive disorder with poor insight: a neuropsychological comparison.
    Tumkaya S; Karadag F; Oguzhanoglu NK; Tekkanat C; Varma G; Ozdel O; Ateşçi F
    Psychiatry Res; 2009 Jan; 165(1-2):38-46. PubMed ID: 18995914
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.